dry nose
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Use of the nasal sprays in adults and children within the intended use - indication for Treatment of dry nose symptoms - at least three of the clinical symptoms have a value of "mild", "moderate", "strong" or "very strong" or at least two symptoms have a value of "strong" or "very strong" - decision of the physician to recommend the use of a nasal spray has been made before the inclusion of the Patient in the Trial - patients are enrolled only after they had been given sufficient Information and had provided written consent
Exclusion criteria
Exclusion criteria: patients that do not fulfill the inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of clinical symptoms by the patients, Rhinitis Sicca Symptom Score. | — |
Secondary
| Measure | Time frame |
|---|---|
| •Evaluation of the nasal spray •Duration of symptom improvement •Endoscopic Evaluation by the physicians •Global evalution by Patient and physician | — |
Countries
Germany
Contacts
URSAPHARM Arzneimittel GmbH